Evidence map›Paper›PMID 40564914›Full record

ArticleInternational journal of molecular sciences2025

Fecal Microbiota Transplantation from Mice Receiving Magnetic Mitohormesis Treatment Reverses High-Fat Diet-Induced Metabolic and Osteogenic Dysfunction.

Jun Kit Craig Wong, Bharati Kadamb Patel, Yee Kit Tai, Tuan Zea Tan, Wei Wei Thwe Khine, Way Cherng Chen, Marek Kukumberg, Jianhong Ching, Lye Siang Lee, Kee Voon Chua and 10 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jun Kit Craig WongDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.ORCID 0000-0002-0840-9922
Bharati Kadamb PatelDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.ORCID 0000-0001-8433-9527
Yee Kit TaiDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Tuan Zea TanGenomics and Data Analytics Core, Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.ORCID 0000-0001-6624-1593
Wei Wei Thwe KhineDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Way Cherng ChenBruker Singapore Pte Ltd., 30 Biopolis St., Singapore 138671, Singapore.
Marek KukumbergHealthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Jianhong ChingCardiovascular and Metabolic Disorders Programme, Duke-NUS Medical School, Singapore 169857, Singapore.ORCID 0000-0003-1526-8459
Lye Siang LeeCardiovascular and Metabolic Disorders Programme, Duke-NUS Medical School, Singapore 169857, Singapore.ORCID 0000-0001-6924-508X
Kee Voon ChuaCardiovascular and Metabolic Disorders Programme, Duke-NUS Medical School, Singapore 169857, Singapore.
Tsze Yin TanCardiovascular and Metabolic Disorders Programme, Duke-NUS Medical School, Singapore 169857, Singapore.ORCID 0000-0002-4119-736X
Kwan Yu WuDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.ORCID 0009-0004-9942-239X
Xizhe BaiDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Jan Nikolas IversenDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.ORCID 0000-0001-5900-2033
Kristy PurnamawatiDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Rufaihah Abdul JalilDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Alan Prem KumarNUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.ORCID 0000-0002-3754-5712
Yuan Kun LeeDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.ORCID 0000-0002-3884-4706
Shabbir M MoochhalaDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Alfredo Franco-ObregónDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.ORCID 0000-0002-2514-1083

Funding

iHealthtech Microbiome in Health, Disease and Aging 2018 Joint Research Grant A-0001177-01-00Ministry of Education MOE-T2EP30120-0016National University Health System NUHSRO/2023/039/RO5+6/Seed-Mar/04
6 · The paper itself

Abstract

This study compared the metabolic consequences of fecal microbiota transplantation (FMT) from donor mice that had been either administered pulsed electromagnetic field (PEMF) therapy or exercised to recipient mice fed a high-fat diet (HFD). Eight weeks of PEMF treatment (10 min/week) enhanced PGC-1α-associated mitochondrial and metabolic gene expression in white and brown adipose to a greater degree than eight weeks of exercise (30-40 min/week). FMT from PEMF-treated donor mice recapitulated these adipogenic adaptations in HFD-fed recipient mice more faithfully than FMT from exercised donors. Direct PEMF treatment altered hepatic phospholipid composition, reducing long-chain ceramides (C16:0) and increasing very long-chain ceramides (C24:0), which could be transferred to PEMF-FMT recipient mice. FMT from PEMF-treated mice was also more effective at recovering glucose tolerance than FMT from exercised mice. PEMF treatment also enhanced bone density in both donor and HFD recipient mice. The gut Firmicutes/Bacteroidetes (F/B) ratio was lowest in both the directly PEMF-exposed and PEMF-FMT recipient mouse groups, consistent with a leaner phenotype. PEMF treatment, either directly applied or via FMT, enhanced adipose thermogenesis, ceramide levels, bone density, hepatic lipids, F/B ratio, and inflammatory blood biomarkers more than exercise. PEMF therapy may represent a non-invasive and non-strenuous method to ameliorate metabolic disorders.

Indexed as

Diet, High-FatFecal Microbiota TransplantationMagnetic Field TherapyMetabolic DiseasesOsteogenesisAnimalsBone DensityCeramidesGastrointestinal MicrobiomeLiverMaleMiceMice, Inbred C57BLCeramidesceramidesgut microbiomenon-alcoholic fatty liver disease (NAFLD)non-alcoholic steatohepatitis (NASH)obesityosteogenesisPEMF therapy

Identifiers

PMID40564914
PMCPMC12193155

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.